Home » IMS 3 Trial of Mechanical Embolectomy in Stroke Stopped
IMS 3 Trial of Mechanical Embolectomy in Stroke Stopped
The Interventional Management of Stroke 3 (IMS 3) trial, which was comparing intravenous tissue plasminogen activator (tPA) alone with combination tPA and intra-arterial therapy using intra-arterial tPA or mechanical thrombectomy in stroke patients, has suspended enrollment after crossing a prespecified interim analysis threshold.
Medscape Today
Medscape Today
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May